1 / 22

HEMORRHAGE RESUSCITATION AND MASSIVE TRANSFUSION PROTOCOLS

HEMORRHAGE RESUSCITATION AND MASSIVE TRANSFUSION PROTOCOLS. CAPT William C. Brunner, MC, USN Senior Medical Officer, BSRF-2013 Assistant Professor, Department of Surgery. Disclosures.

overton
Télécharger la présentation

HEMORRHAGE RESUSCITATION AND MASSIVE TRANSFUSION PROTOCOLS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HEMORRHAGE RESUSCITATIONANDMASSIVE TRANSFUSION PROTOCOLS CAPT William C. Brunner, MC, USN Senior Medical Officer, BSRF-2013 Assistant Professor, Department of Surgery

  2. Disclosures The speaker has no relevant financial relationships with commercial interests that pertain to the content of this presentation

  3. Objectives • Review History of Trauma Resuscitation • Discuss Coagulopathies in Trauma • Discuss Integrated Damage Control • Review Blood Component Preparations • Discuss Individual Component Transfusion Guidelines • Discuss Massive Transfusion Protocols • Discuss Future Research Areas

  4. History of Trauma Resuscitation • World War I • Little or no systematic resuscitation after injury • Blood banking developed • World War II • Widespread use of blood and albumin • Long, slow evacuation • Significant organ failure – renal, pulmonary • Late deaths from sepsis

  5. History of Trauma Resuscitation • Korean War • Forward Surgical Care • Rapid Care • Evacuation to Definitive Treatment • Blood and albumin as in WWII • Vietnam War • Rapid evacuation • Large-volume resuscitation with blood/crystalloid • Da Nang Lung (ALI/ARDS)

  6. History of Trauma Resuscitation • Civilian Experience • Trauma Registries and Research • Empiric high-volume crystalloid resuscitation • Iatrogenic Coagulopathy after Trauma recognized • Directed Component Therapy • Requires Laboratory evidence • Empiric therapy limited • Massive Transfusion Protocols

  7. History of Trauma Resuscitation • Military Experience – Iraq and Afghanistan • Limited Component availability • Recognition of crystalloid inflammatory response • Whole blood transfusion • Walking Blood Bank • Simple technology • Screened donor population readily available

  8. Acute Traumatic Coagulopathy • Recognized in patients with significant tissue injury and hypotension • Distinct from iatrogenic coagulopathy after trauma • Dilutional coagulopathy • Present prior to resuscitation in rapidly evacuated severe trauma • Mortality rate increased 4x • Modulated through protein C activation

  9. Integrated Response • Damage Control Surgery • Rapid, limited, forward surgical care • Control bleeding • Control spillage • Control contamination • Restore perfusion • Avoid unnecessary interventions • Allow for resuscitation • Rapid evacuation • Hemostatic Resuscitation • Limited volume • Permissive hypotension • Balanced transfusion • High FFP:PRBC ratio • Colloid vs. crystalloid • Attenuate ATC • Expand resource availability • Walking blood bank • Freeze-dried plasma

  10. Blood Components

  11. Component Therapy • Advantages • Wider use of limited resources • 1 donated unit – multiple products • Longer storage life • Lower costs in elective use • More predictable availability • Disadvantages • Multiple donor antigen exposure • Less efficacy in high volumes, Lab costs

  12. Component Transfusion Guidelines • Fresh Frozen Plasma • Prothrombin Time (PT) > 17 sec • Clotting Factor Deficiency (<25% of normal) • Massive Transfusion (1 unit/5units RBCs) or clinically bleeding • Severe Traumatic Brain Injury • Cryoprecipitate • Fibrinogen < 100mg/dL • Hemophilia A, von Willebrand disease • Severe Traumatic Brain Injury

  13. Component Transfusion Guidelines • Platelets • Platelet count < 10,000/uL • Platelet count 10,000 to 20,000 with bleeding • Platelet count < 50,000 after severe trauma • Bleeding Time > 15 mins • Platelet concentrates (5.5 x 1010 in 50ml) • Platelet apheresis (3 x 1011 in 300ml)

  14. Component Transfusion Guidelines • Packed Red Blood Cells (PRBCs) • Hemoglobin < 7g/dL • Acute blood volume loss > 15% • > 20% decrease in BP, or BP <100mm Hg due to blood loss • Hemoglobin < 10g/dL with significant cardiac disease or symptoms (chest pain, dyspnea, fatigue, orthostatic hypotension) • Hemoglobin < 11g/dL in patient at risk for MOF

  15. Massive Transfusion • Defined as > 10 units PRBCs within 24 hrs • 25-30% of trauma patients requiring massive transfusion will present with Acute Traumatic Coagulopathy (ATC) • Penetrating mechanism • Positive FAST • Arrival SBP < 90mm Hg, HR > 120 bpm • Unstable pelvic fracture • pH < 7.25, base deficit

  16. Massive Transfusion Protocol • Advantages • More closely replicate whole blood physiology with components • Retain shelf-life advantage of components • 25-30% reduction in PRBCs used • Predictable workload • Disadvantages • Processing time limitations • Limited applicability

  17. Massive Transfusion Protocol Data from O’Keeffe T, Refaai M, Tchorz K, et al: A massive transfusion protocol to decrease blood component use and costs, Arch Surg 143:686-691, 2008.

  18. Massive Transfusion Protocol • Typically start with 2-6 units Type O blood • Initial “emergency-release” • Subsequent units type-specific, cross-matched • FFP processing time • ER prestaging thawed plasma, shelf-life 4-5 days • Protocols can enhance effective use of staffing and resources

  19. Special Situations • Autotransfusion • Limited applicability due to capture, possible contamination • Blood salvage • Intraoperative or postoperative • Labor intensive, expensive, limited utility • Autologous donation, Hemodilution not applicable to trauma setting

  20. Areas for Future Study • Determine optimal therapeutic ratio of PRBC:FFP • PROPPR Study - 1:1:1 vs. 1:1:2 PRBC/PLT/FFP • Further delineate ATC physiology and identify clinically useful modulators • Delineate impact of high-ratio therapy on sub-MT trauma population • Blood component substitutes • Crystalloid alternatives

  21. References • McIntyre RC Jr., Moore FA; Blood Transfusion Therapy, Chapter 212, Current Surgical Therapy, 10th Edition, Philadelphia, PA, 2011. • Adams CA Jr., Stephen A, Cioffi WG; Surgical Critical Care, Chapter 23, Sabiston Textbook of Surgery, 19th Edition, Philadelphia, PA 2012. • Chovanes J, Cannon JW, Nunez TC; The Evolution of Damage Control Surgery, SurgClin N Am 92 (2012) 859-875.

  22. References • Cohen MJ. Towards Hemostatic Resuscitation: The Changing Understanding of Acute Traumatic Biology, Massive Bleeding, and Damage-Control Resuscitation. SurgClin N Am 92 (2012) 877-891. • Committee on Trauma, American College of Surgeons. ATLS: Advanced Trauma Life Support Student Course Manual, 9th Edition. Chcago: American College of Surgeons; 2012.

More Related